NEW YORK, April 5, 2024 / ACCESSWIRE /
Anavex Life Sciences Corporation (NASDAQ:AVXL)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that Anavex misled investors by providing a materially flawed and inaccurate impression of Anavex's research program and of blarcamesine's actual likelihood of success in its Phase II/Phase III Rett syndrome trials.
If you are an AVXL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Shoals Technologies Group, Inc. (NASDAQ:SHLS)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company did not deliver electrical balance of system ("EBOS") products that met the highest levels of quality and reliability; (ii) the Company had received reports of exposed copper conduit in EBOS wire harnesses in a large number of solar fields and was aware that a significant portion of its wire harnesses had defects; (iii) the Company would have to incur between $60 million to $185 million in costs to remediate the wire shrinkback issue; and (iv) the Company had understated its cost of revenue by millions of dollars.
If you are a SHLS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
The Chemours Company (NYSE:CC)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose that: (i) certain of the Company's senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company's AIPs and LTIPs; (ii) the Company's accounting practices and procedures, including its internal control over financial reporting, were deficient; and (iii) the Company's statements about its business, operations, and prospects lacked a reasonable basis.
If you are a CC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Agilon Health, Inc. (NYSE:AGL)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company misled investors about the Company's medical costs by: (i) touting the Company's purported visibility into utilization trends and medical costs; (ii) failing to disclose increased medical costs that the Company had incurred due to higher utilization of healthcare by Medicare Advantage patients; (iii) falsely stating that its IBNR Reserve was adequate; (iv) making false and misleading statements about the effectiveness of its business model; (v) issuing overly optimistic financial guidance; and (vi) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.
If you are an AGL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: jlifshitz@lifshitzlaw.com
SOURCE: Lifshitz Law Firm, P.C.
View the original
press release on accesswire.com
